OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $20,000 | -41.2% | 4,079 | -5.2% | 0.00% | – |
| Q1 2015 | $34,000 | -91.3% | 4,305 | -93.3% | 0.00% | – |
| Q4 2014 | $391,000 | +171.5% | 64,527 | +90.7% | 0.00% | – |
| Q3 2014 | $144,000 | -30.1% | 33,829 | +1.6% | 0.00% | – |
| Q2 2014 | $206,000 | -22.0% | 33,302 | -18.2% | 0.00% | – |
| Q1 2014 | $264,000 | +53.5% | 40,725 | +33.1% | 0.00% | – |
| Q4 2013 | $172,000 | -14.9% | 30,587 | -7.2% | 0.00% | – |
| Q3 2013 | $202,000 | -39.0% | 32,968 | -41.7% | 0.00% | -100.0% |
| Q2 2013 | $331,000 | – | 56,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |